Pfizer exits Chinese generic drugs JV, Hisun-Pfizer Pharmaceuticals

In a significant shift within the pharmaceutical industry, Pfizer Inc. has announced its decision to exit the Hisun-Pfizer Pharmaceuticals joint venture by divesting its 49% ... Read More